Alice S. Cho and David A. Rodriguez will join the Globe Life board (pictured above) that includes Linda L. Addison, Of Counsel, Norton Rose Fulbright US LLP; Marilyn A. Alexander, Principal, Alexander and Friedman LLC; Cheryl D. Alston, Executive Director and Chief Investment Officer, Employees’ Retirement Fund of the City of Dallas, Texas; Mark A. Blinn, Former President and CEO of Flowserve Corporation; James P. Brannen, Retired CEO of FBL Financial Group, Inc.; Jane Buchan, CEO, Martlet Asset Management LLC; Gary L. Coleman, Co-Chairman, Globe Life Inc.; Larry M. Hutchison, Co-Chairman, Globe Life Inc.; Robert W. Ingram, Retired Ross-Culverhouse Professor of Accounting, Culverhouse College of Commerce, University of Alabama; Steven P. Johnson, Retired Partner, Deloitte and Touche LLP; Darren M. Rebelez, President and CEO, Casey's General Stores Inc.; Mary E. Thigpen, Consultant for Digital Transformation Strategies, Technology and Cybersecurity Assessments, and Systemic Risk Mitigation Competencies. [Photo: Globe Life]
McKinney-based Globe Life Inc. announced that Alice S. Cho, senior adviser to the Boston Consulting Group, and David A. Rodriguez, former EVP and global chief human resources officer of Marriott International Inc., were appointed to its board of directors.
Cho brings extensive board experience in financial services, risk management, regulatory compliance, corporate governance, and digital technology issues via her advisory and management positions at Boston Consulting Group, Promontory Financial Group, BITS (Bank Policy Institute), the Federal Reserve Board, and the U.S. Executive Office of the President.
She also serves on the board of First Interstate BancSystem.
Rodriguez brings to the board extensive experience in human resource management, including organizational culture and inclusion, from a 36-year career at companies including Marriott International, Citicorp/Citibank, and Avon Products. He also serves on the board of American Woodmark Corp. and the board of trustees of the SIOP Foundation.
Globe Life Inc. is a holding company specializing in life and supplemental health insurance for “middle income” Americans marketed through multiple distribution channels including direct to consumer and exclusive and independent agencies.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
Girls Inc. of Metropolitan Dallas is expanding its impact in helping girls dream big and learn skills for life-long success with help from Capital One.
-
CEOs of the 100 fastest-growing privately held companies in the Dallas region joined the SMU Cox Caruth Institute for Entrepreneurship for the kickoff of its annual celebration of the entrepreneurial spirit on Thursday. Now the countdown begins for the institute's Nov. 2 reveal of which one is THE fastest-growing privately held company in Dallas-Fort Worth. Here are the contenders.
-
Fossil Group Inc. announced the addition of respected beauty and fashion executive Suzanne (Susie) Coulter to its board of directors, expanding the size of the board to eight members, including seven independent directors. Richardson-based Fossil Group is a global design, marketing, distribution, and innovation company specializing in lifestyle accessories. "Susie's immense retail background, from corporate leadership and entrepreneurship to more specific expertise in retail strategy, operations, merchandising, and supply chain, will be invaluable to our Board of Directors," Kosta N. Kartsotis, chairman and CEO of Fossil Group, said in a statement. "We look forward to having her join our board…
-
The once-a-year summit on September 22 and 23 is an innovation multiplier for capital, collaboration, and commercialization. Experts in the field will discuss strategy and exchange insights—and what's driving life science success across the region.
-
Dallas-based life science company ReCode Therapeutics has appointed Patricia "Trisha" Millican to its board of directors, bringing with her more than 20 years of experience in the life science industry. ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. Shehnaaz Suliman, M.D., MBA, M.Phil., chief executive officer and a board member of ReCode Therapeutics, says Millcan brings "decades of proven strategic financial leadership and extensive biopharmaceutical industry experience to ReCode, an ideal complement to the existing makeup of our Board members." The CEO says the company looks forward…